108837-20-3

Basic information

• Product Name: 4H-1-Benzopyran-4-one, 2,3-dihydro-7-hydroxy-2-(4-methoxyphenyl)-
• CAS NO: 108837-20-3
• Molecular Formula: C16H14O4
• Molecular Weight: 270.285
• Mol File: 108837-20-3.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: 4H-1-Benzopyran-4-one, 2,3-dihydro-7-hydroxy-2-(4-methoxyphenyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: 4H-1-Benzopyran-4-one, 2,3-dihydro-7-hydroxy-2-(4-methoxyphenyl)-(108837-20-3)
• EPA Substance Registry System: 4H-1-Benzopyran-4-one, 2,3-dihydro-7-hydroxy-2-(4-methoxyphenyl)-(108837-20-3)

Safety Data

• Hazardous Substances Data: 108837-20-3(Hazardous Substances Data)

Upstream product

• 89-84-9 2',4'-dihydroxy-4-acetophenone 
• 123-11-5 4-methoxy-benzaldehyde 
• 65490-08-6 2-hydroxy-4-(methoxymethoxy)acetophenone 
• 109471-14-9 2'-hydroxy-4'-(methoxymethoxy)-4-methoxychalcone 
• 81674-91-1 1-(2,4-dihydroxyphenyl)-3-(4-methoxyphenyl)-prop-2-en-1-one 
• 13351-10-5 2',4'-dihydroxy-4-methoxychalcone 

Relevant articles and documents

7-Hydroxy-4'-methoxyflavanone

The γ-pyrone ring of the title molecule adopts the C2-sofa conformation; the C2 and C3 atoms show disorder.The 2-phenyl substituent is twisted out of the benzo-γ-pyrone

Glycolytic inhibition and antidiabetic activity on synthesized flavanone scaffolds with computer aided drug designing tools

Background: Diabetes mellitus is a challengeable metabolic disorder that leads to a group of complications when the HbA1c level is not maintained. Most of the existing drugs avail-able in the market in long-term use may lead to serious adverse effects. He

Design, Synthesis, and Potential Antidepressant-like Activity of 7-prenyloxy-2,3-dihydroflavanone Derivatives

A series of 7-prenyloxy-2, 3-dihydroflavanone derivatives were synthesized and screened for their antidepressant-like activity. Among them, it was observed that compounds 5j and 5k were found to be the most antidepressant-like activity. In addition, it was found that compounds 5j and 5k significantly increased the concentrations of the main neurotransmitters 5-HT and NE in the hippocampus, hypothalamus, and cortex. Compounds 5j and 5k also significantly increased the contents of 5-HIAA in the hippocampus and cortex, shut down 5-HT metabolism compared with mice treated with stress vehicle. These results suggested that compounds 5j and 5k displayed potent antidepressant-like properties that were mediated via neurochemical systems.